These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 7882633)
21. Women's health initiative leads way as research begins to fill gender gaps. Cotton P JAMA; 1992 Jan 22-29; 267(4):469-70, 473. PubMed ID: 1729560 [No Abstract] [Full Text] [Related]
22. Ethical considerations? A commentary on ACOG committee opinion 213: "Ethical considerations in research involving pregnant women". Sharpe VA Womens Health Issues; 1999; 9(4):199-201. PubMed ID: 10438202 [No Abstract] [Full Text] [Related]
23. Harms of excluding pregnant women from clinical research: the case of HIV-infected pregnant women. Kass NE; Taylor HA; King PA J Law Med Ethics; 1996; 24(1):36-46. PubMed ID: 8925011 [No Abstract] [Full Text] [Related]
24. The Institute of Medicine's report on women and health research: implications for IRBs and the research community. Rothenberg KH IRB; 1996; 18(2):1-3. PubMed ID: 11654754 [No Abstract] [Full Text] [Related]
25. From the Food and Drug Administration. Nightingale SL JAMA; 1993 Sep; 270(11):1290. PubMed ID: 8360956 [No Abstract] [Full Text] [Related]
26. Why single out pregnant women? Comments on ACOG's recommendations for involving pregnant women in research. Roche PA; Grodin MA Womens Health Issues; 1999; 9(4):202-5. PubMed ID: 10438203 [No Abstract] [Full Text] [Related]
27. Off the pedestal and into the arena: toward including women in experimental protocols. Gorenberg H; White A Rev Law Soc Change; 1991-1992; 19(1):205-46. PubMed ID: 11659599 [No Abstract] [Full Text] [Related]
28. Women and health research: a report from the Institute of Medicine. Mastroianni AC; Faden R; Federman D Kennedy Inst Ethics J; 1994 Mar; 4(1):55-62. PubMed ID: 10132589 [No Abstract] [Full Text] [Related]
29. Women in clinical trials: an FDA perspective. Sherman LA; Temple R; Merkatz RB Science; 1995 Aug; 269(5225):793-5. PubMed ID: 7638593 [No Abstract] [Full Text] [Related]
30. Informed consent: the FDA's perspective. Bagley G Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141 [No Abstract] [Full Text] [Related]
33. Women in clinical studies: a feminist view. Sherwin S Camb Q Healthc Ethics; 1994; 3(4):533-8. PubMed ID: 7858752 [No Abstract] [Full Text] [Related]
34. Ethical considerations in research involving pregnant women. Chervenak FA; McCullough LB Womens Health Issues; 1999; 9(4):206-7. PubMed ID: 10438204 [No Abstract] [Full Text] [Related]
35. HIV, women, and access to clinical trials: tort liability and lessons from DES. Mastroianni AC Duke J Gend Law Policy; 1998; 5(1):167-91. PubMed ID: 11979601 [No Abstract] [Full Text] [Related]
36. Women's health, public welfare. Healy B JAMA; 1991 Jul 24-31; 266(4):566-8. PubMed ID: 2061987 [No Abstract] [Full Text] [Related]
37. Women and drug users: the changing faces of HIV clinical drug trials. Murphy TF QRB Qual Rev Bull; 1991 Jan; 17(1):26-32. PubMed ID: 1900931 [No Abstract] [Full Text] [Related]
38. The sex-bias myth in medicine. Kadar AG Atl Mon; 1994 Aug; 274(2):66-70. PubMed ID: 11659876 [No Abstract] [Full Text] [Related]
39. Women in clinical trials: are sponsors liable for fetal injury? Sandomire H J Law Med Ethics; 1993; 21(2):217-30. PubMed ID: 8130832 [No Abstract] [Full Text] [Related]
40. Office of Women's Health, Food and Drug Administration: future directions for women's health. Wood SF J Am Med Womens Assoc (1972); 2001; 56(4):197-8. PubMed ID: 11759792 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]